Applied Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Applied Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2019 to Q3 2024.
  • Applied Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 141 %, a 55.8% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 141 +50.7 +55.8% Sep 30, 2024
Q2 2024 142 +39.2 +38.2% Jun 30, 2024
Q1 2024 114 -7.03 -5.83% Mar 31, 2024
Q4 2023 82.4 -69.2 -45.6% Dec 31, 2023
Q3 2023 90.7 -103 -53.1% Sep 30, 2023
Q2 2023 103 -161 -61% Jun 30, 2023
Q1 2023 121 -272 -69.3% Mar 31, 2023
Q4 2022 152 -341 -69.2% Dec 31, 2022
Q3 2022 194 -341 -63.8% Sep 30, 2022
Q2 2022 263 -343 -56.6% Jun 30, 2022
Q1 2022 393 -265 -40.3% Mar 31, 2022
Q4 2021 493 -286 -36.7% Dec 31, 2021
Q3 2021 535 -242 -31.2% Sep 30, 2021
Q2 2021 607 -218 -26.4% Jun 30, 2021
Q1 2021 657 -162 -19.7% Mar 31, 2021
Q4 2020 778 +343 +78.8% Dec 31, 2020
Q3 2020 777 +274 +54.5% Sep 30, 2020
Q2 2020 825 Jun 30, 2020
Q1 2020 819 Mar 31, 2020
Q4 2019 435 Dec 31, 2019
Q3 2019 503 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.